Frédéric Porte
Fondateur chez Medipress Management, Inc.
Postes actifs de Frédéric Porte
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Medipress Management, Inc. | Fondateur | 20/08/2009 | - |
| President | - | - |
Historique de carrière de Frédéric Porte
Anciens postes connus de Frédéric Porte
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Avance Pharma, Inc.
 Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | 01/01/2005 | 01/01/2005 |
| Clinidata, Inc. | Fondateur | 01/01/1994 | 01/01/1994 |
| President | - | 01/01/1994 | |
| L’Actualité Médicale, Inc. | Fondateur | 22/12/2010 | - |
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Private Equity Investor | 01/01/2008 | - |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Président | 29/01/2007 | - |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | 01/01/1998 | - |
Formation de Frédéric Porte
| EM Lyon Business School | Undergraduate Degree |
| Ecole de Commerce Européenne Bordeaux et Lyon | Undergraduate Degree |
Statistiques
Internationale
| Canada | 8 |
| France | 3 |
Opérationnelle
| Founder | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Finance |
Avance Pharma, Inc.
Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Health Technology |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
| Medipress Management, Inc. | |
| Clinidata, Inc. | |
| L’Actualité Médicale, Inc. |
- Bourse
- Insiders
- Frédéric Porte
- Expérience
